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ORIGINAL ARTICLE
Prevention of Incident Knee Osteoarthritis by
Moderate Weight Loss in Overweight and
Obese Females
JOS RUNHAAR,1 BASTIAAN C. DE VOS,1 MARIENKE VAN MIDDELKOOP,1 DAMMIS VROEGINDEWEIJ,2
EDWIN H. G. OEI,1 AND SITA M. A. BIERMA-ZEINSTRA1
Objective. This study evaluated the effect of moderate weight loss on the incidence of knee osteoarthritis (OA) in
middle-aged overweight and obese women, without clinical and radiologic knee OA at baseline.
Methods. A total of 353 women (87%) with followup data available were selected from the Prevention of Knee
Osteoarthritis in Overweight Females study, which evaluated the preventive effect of a diet and exercise intervention
and of oral glucosamine sulfate on the incidence of knee OA. This was an exploratory proof-of-concept analysis,
which compared the incidence of knee OA between women who reached the clinically relevant weight loss target of
5 kg or 5% of body weight after 30 months and those who did not reach this target.
Results. The weight loss group showed a significantly lower incidence of knee OA according to the primary outcome
measure, which was composed of the American College of Rheumatology criteria (clinical and radiographic),
Kellgren/Lawrence grade ‡2, and joint space narrowing ‡1.0 mm (15% versus 20%; odds ratio 0.5, 95% confidence
interval 0.3–0.9). Moreover, the weight loss also positively affected several health measures, such as blood glucose
level, body fat percentage, and blood pressure.
Conclusion. A reduction of ‡5 kg or 5% of body weight over a 30-month period reduces the risk for the onset of
radiographic knee OA in middle-aged overweight and obese women. Because of the slow progression of the disease, a
longer followup period will be necessary before the number of prevented cases of knee OA by moderate weight loss
becomes clinically more relevant.
INTRODUCTION
The worldwide prevalence of obesity nearly doubled
between 1980 and 2008 (1). According to the most recent
estimates by the World Health Organization, 35% of all
adults are overweight (body mass index [BMI] $25 kg/m2)
and more than 12% are obese (BMI $30 kg/m2) (1). A high
BMI is a strong risk factor for the onset of knee osteoarthri-
tis (OA) (2–4) and has been associated with the incidence
of both clinical (5–7) and structural (8–13) features of knee
OA. Given the high medical costs, productivity costs,
morbidity, and disability associated with knee OA, there
is an increasing need for preventive measures (14).
In trials among subjects with and without established
knee OA, weight loss was shown to have advantageous
structure-modifying, systemic, and clinical effects
(15–21). In a systematic review on the effects of weight
loss on knee OA patients, a weight loss of at least 5% of
body weight was indicated for symptomatic relief (22).
Losing 5 kg or 5% of body weight has also been indicated
as the minimum weight loss necessary for a positive and
clinically relevant effect on cardiovascular risk profile,
including significant reduction of blood pressure and
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improved glucose tolerance (23). In subjects without knee
OA but with overweight or obesity, and hence at high risk
for developing knee OA, the preventive effect of such a
clinically relevant weight reduction has never been stud-
ied. Using results from the Framingham Osteoarthritis
Study, it has been estimated that moderate weight loss
(approximately 5 kg) could reduce the onset of knee OA in
overweight and obese subjects (24,25).
Recently, the first preventive trial in OA research, the
Prevention of Knee Osteoarthritis in Overweight Females
(PROOF) study, was undertaken (26). In this randomized
clinical trial among middle-aged women with a BMI
$27 kg/m2 without knee OA at baseline, the effects of a
diet and exercise program on the incidence of knee OA
over 2.5 years was studied. The diet and exercise program
did show favorable effects on body weight in the interven-
tion group during the first year of the intervention, and
indications of a preventive effect among subjects compli-
ant with the intervention were found (26). The objective
of the diet and exercise intervention was a structural
weight reduction of 5 kg or 5% of baseline body weight.
The primary objective of the present study is to evaluate
the effects of a clinically relevant reduction in body
weight ($5 kg or 5%), irrespective of the original interven-
tions, on the incidence of clinical and radiologic knee OA
after 2.5 years in middle-aged overweight and obese
women.
PATIENTS AND METHODS
For this study we used data from the PROOF study. A full
description of the study protocol can be found elsewhere
(26). In short, this 2.5-year followup study aimed to evalu-
ate the preventive effect of a diet and exercise program
and oral glucosamine sulfate (double-blind, placebo-con-
trolled) on the onset of knee OA in a 23 2 factorial design.
The study protocol was approved by the Medical Ethical
Committee of Erasmus Medical Center. This article was
prepared in accordance with the Strengthening the
Reporting of Observational Studies in Epidemiology state-
ment (27). For the present study, the predefined hypothe-
sis, stating that losing 5 kg or 5% of baseline body weight
had a preventive effect on knee OA, was tested.
Fifty general practitioners in Rotterdam, The
Netherlands, contacted all women ages 50–60 years regis-
tered at their practice. All women who returned the reply
card, reported a BMI $27 kg/m2, and were interested in
participating were sent additional information. One week
later, these women were screened by phone to determine
whether or not they met the study inclusion criteria.
Inclusion criteria were 50–60 years of age, BMI $27 kg/m2,
not meeting American College of Rheumatology (ACR) cri-
teria for OA (28), no contraindications for magnetic reso-
nance imaging, no rheumatic diseases, not using a
walking aid, not under treatment for knee symptoms, mas-
tery of the Dutch language, and not taking oral glucos-
amine during the past 6 months. Here, ACR criteria
concerned the clinical criteria only, since screening at this
stage was done by phone. All other references to ACR cri-
teria in the present article refer to those measured with
clinical and radiographic data. All women eligible and
willing to participate were invited to visit the research
institute for informed consent procedure and baseline
measurements. The period of recruitment ran from July
2006 until May 2009.
At baseline, body weight and height, waist circumfer-
ence, and blood pressure were measured. Skin folds of the
triceps were measured and used to calculate body fat per-
centage using the formula by Lean et al (29), which was
considered the most reliable method based on simple
anthropometric measurements in women.
fat percentage5 0:733BMI10:5483 triceps skin foldð Þ
1 0:273 ageð Þ2 5:9
A blood sample was taken to assess total blood cholesterol
and glycosylated hemoglobin (HbA1c) concentration, and
Heberden’s nodes on both hands were assessed. A stan-
dardized semiflexed posteroanterior radiograph of both
knees was taken according to metatarsophalangeal proto-
col (30). All subjects filled out a questionnaire that
included questions on knee symptoms, number of days
with knee pain, past knee injuries, and postmenopausal
status. Knee symptoms were defined as having any knee
pain in the past 12 months. All measurements were
repeated after 2.5 years of followup.
All tibiofemoral compartments of all knees were scored
for knee OA by a researcher blinded to clinical outcomes
(baseline and followup images at once, with known
sequence), using the Kellgren/Lawrence (K/L) scale
(k50.6) (31). Also, alignment of the knee was assessed
and varus alignment was defined as having an angle of
less than 178 degrees on the baseline radiograph. Minimal
joint space width (intraclass correlation 0.67–0.76) was
measured digitally on each radiograph in each tibiofem-
oral compartment independently by 2 blinded researchers
(JR and BCdV), according to the Lequesne method (32).
Scores with a difference of$2.0 mm between the 2 readers
were reevaluated by both readers at a consensus meeting.
Joint space narrowing (JSN) was calculated for each tibio-
femoral compartment by subtracting the mean score of
both assessors at baseline from the mean score at
followup.
Significance & Innovations
 To our knowledge, this is the first time that the
preventive effect of moderate weight loss (5 kg
or 5% of body weight) on incident knee osteoar-
thritis (OA) has been studied.
 This study serves as a proof-of-concept that mod-
erate weight loss can, in fact, prevent incident
knee OA in a high-risk population of overweight
and obese women.
 This article contributes to preventive studies in
OA, which are lacking, especially in a primary
care setting.
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For the analyses, all subjects with the primary outcome
measure and followup data on body weight available were
selected. Baseline characteristics were tested for signifi-
cant difference between the weight loss and non–weight
loss groups using an independent t-test for linear mea-
sures and the chi-square test for dichotomous measures.
Using the generalized estimating equation (GEE), which
takes into account the association between knees within
subjects, we compared the incidence of knee OA in sub-
jects who reached the weight loss target of 5 kg or 5%
body weight reduction at 2.5 years to subjects who did
not. The predefined primary outcome measure was the
incidence of knee OA, defined as the incidence of K/L $2
or ACR criteria (clinical and radiographic) or JSN
$1.0 mm in the medial or lateral tibiofemoral compart-
ment. JSN of 1.0 mm was chosen as the cutoff because the
population concerned is a population without knee OA
and thus with healthy cartilage thickness. We hypothe-
sized that less than 1.0 mm would be of questionable clin-
ical interest in this population. Since the initial screening
was done by phone, we anticipated that a proportion of
participants would meet the criteria of one of the compo-
nents of the primary outcome measure at baseline. These
participants would be included in the analysis, defining
development of knee OA during the followup period as
meeting the criteria of one of the other components of the
primary outcome measure. As a sensitivity analysis, we
also analyzed differences between the weight loss and
non–weight loss groups for the separate items of the pri-
mary outcome measure. For these analyses, participants
who met the criteria for that specific outcome measure at
baseline were excluded. All GEE analyses were adjusted
for the randomized groups of the initial PROOF study and
their interaction and for K/L grade at baseline (0 versus
$1), since it was shown to be related to the incidence of
knee OA (26), and for those factors that were significantly
different between the weight loss and non–weight loss
groups at baseline. Results from these analyses were pres-
ented in odds ratios (ORs) with 95% confidence intervals
(95% CIs). Baseline differences between the weight loss
and non–weight loss groups were tested using Student’s
t-test for continuous variables and Pearson’s chi-square
test for categorical variables. To evaluate the magnitude of
the changes in clinical outcomes after a weight reduction
of 5 kg or 5% of body weight, changes over the 2.5-year
followup period on total cholesterol, HbA1c level, body fat
percentage, waist circumference, and blood pressure
between the weight loss and non–weight loss groups were
assessed using Student’s t-test. All statistical analyses
were performed using SPSS, version 20.0, with a P value
less than 0.05 regarded as statistically significant.
RESULTS
After 2.5 years, the primary outcome measure and fol-
lowup data on body weight was available for 353 women
(87%). The reasons the remaining 54 participants were
lost to followup were as follows: 1 was unavailable, 1 had
no radiograph at baseline, 9 had no radiograph at fol-
lowup, 38 were unwilling and dropped out during fol-
lowup, 2 dropped out due to glucosamine side effects, 1
had no questionnaire data at followup, and 2 died during
the course of the study. The participants who were lost to
followup had a slightly lower BMI (mean6SD 32.364.1
versus 33.16 5.0) and more often had a history of knee
injury (14% versus 6%). Both of these differences were
significant (P, 0.05). Of the other variables, there were no
significant differences between the participants who were
lost to followup and those who completed the study. Of
those who completed the study, 61 (17%) fulfilled the
weight loss target of 5 kg or 5% body weight. This group
was defined as the weight loss group, which we compared
to the other 292 participants, called the non–weight loss
group. Baseline characteristics of both groups are pres-
ented in Table 1.
As expected, there was a proportion of participants with
knee OA at baseline, which we knew from the initial
screening by phone. A number of participants (3.9%) met
ACR criteria at baseline and 6.6% of participants had a
K/L grade of 2 or higher. As stated in the Patients and
Methods section, these participants were not excluded
from the analysis. However, for sensitivity analysis, these
Table 1. Baseline characteristics for weight loss and non–weight loss groups*
Non–weight loss Weight loss P
Subjects, no. 292 61
Mean6SD age, years 55.86 3.2 55.56 3.2 0.42
Mean6SD BMI, kg/m2 32.06 4.1 33.46 4.3 , 0.01
Postmenopausal 69 73 0.33
Heberden’s nodes in $1 finger 28 25 0.58
Knees, no. 584 122
Kellgren/Lawrence grade 0 52 43 0.11
Kellgren/Lawrence grade $1 48 57
History of knee injury 12 21 0.01
Knee OA symptoms† 31 33 0.75
Varus alignment‡ 39 43 0.36
* Values are percentages unless otherwise indicated. BMI5 body mass index; OA5 osteoarthritis.
† Knee OA symptoms defined as having knee pain in the last 12 months.
‡ Varus alignment of the knee defined as an angle of ,178 degrees on the baseline radiograph.
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participants were excluded from the analyses with the
separate components of the primary outcome measure as
the outcome measure.
At baseline, the mean BMI (P50.01) and the number of
knees with a past injury (P5 0.01) were significantly
higher in the weight loss group. Hence, the analyses
were additionally adjusted for these variables. The weight
change in the weight loss group over the 2.5 years of
followup was 29.96 5.7 kg on average (range 24.2 kg to
224.7 kg). In the non–weight loss group, subjects gained
1.86 4.0 kg on average (range 24.8 to 121.2 kg). The
mean change in BMI was ,3.6 kg/m2 in the weight loss
group and 10.7 kg/m2 in the non–weight loss group.
Incidence figures of knee OA according to the primary out-
come and the separate items and corresponding ORs for
the weight loss group relative to the non–weight loss
group are presented in Table 2.
Incidence according to the primary outcome measure
was 20% in the non–weight loss group and 15% in the
weight loss group (OR 0.50, 95% CI 0.27–0.93). Also, the
difference in the incidence of a K/L grade $2 between the
non–weight loss group (6%) and the weight loss group
(3%) was statistically significant (OR 0.28, 95% CI 0.08–
0.90). The other outcome measures showed no significant
difference between the 2 groups.
Subjects in the weight loss group had a significant
reduction in HbA1c level (21.4 versus 0.4 mmole/mole;
P5 0.03), fat percentage (24.7% versus 20.1%; P, 0.01),
waist circumference (27.3 cm versus 1.5 cm; P, 0.01),
and systolic (25.3 mm Hg versus 0.2 mm Hg; P50.04)
and diastolic (27.9 mm Hg versus 22.8 mm Hg; P,0.01)
blood pressure over the 2.5-year followup period com-
pared to subjects in the non–weight loss group.
DISCUSSION
To our knowledge, this is the first time that the preventive
effect of moderate weight reduction on incident knee OA
in a high-risk group of middle-aged women with a BMI
$27 kg/m2 has been studied. Previously, 1 study reported
a preventive effect of weight loss on cartilage thickness of
the knee (18). However, this was an observational study
without validated clinical or radiologic OA outcomes,
making the results less applicable in clinical practice.
Recently, a study reported on the preventive effect of an
intensive diet and exercise program on knee pain and
showed evidence of a preventive effect of a weight loss
intervention on knee pain (33). However, knee OA figures
were not presented since no radiographs were taken.
Moreover, the present study reports on an effect of moder-
ate weight loss, which makes it more applicable in pri-
mary care.
The intention-to-treat analysis of the original PROOF
study showed no significant main effects of the diet and
exercise program or the glucosamine versus placebo inter-
vention on the incidence of knee OA over 2.5 years. The
present study, as a proof-of-concept, shows that a clini-
cally relevant weight reduction of 5 kg or 5% of body
weight or more leads to significantly fewer incident cases
of knee OA in overweight and obese women.
The PROOF study used a combined outcome measure of
radiographic and clinical knee OA features in order to
make a preventive randomized trial with a relatively short
followup time feasible (26). In the non–weight loss group,
6% of all knees had incident radiographic knee OA (K/L
$2) over the followup period. This annual incidence of
2.4% is at the high end of the range found in population-
based cohorts using the same criterion, such as the






Weight loss group 18/122 (15) 0.50 (0.27–0.93)
Non–weight loss group 117/584 (20) 1
Kellgren/Lawrence grade $2
Weight loss group 3/118 (3) 0.27 (0.08–0.90)
Non–weight loss group 33/545 (6) 1
American College of Rheumatology criteria
Weight loss group 6/122 (5) 0.34 (0.09–1.32)
Non–weight loss group 41/584 (7) 1
Medial joint space narrowing $1.0 mm
Weight loss group 6/122 (5) 0.65 (0.26–1.67)
Non–weight loss group 34/583 (6) 1
Lateral joint space narrowing $1.0 mm
Weight loss group 7/122 (6) 0.74 (0.32–1.70)
Non–weight loss group 40/583 (7) 1
* Weight loss group defined as $5 kg or 5% weight loss and non–weight loss group as ,5 kg or 5%
weight loss. OA5 osteoarthritis; 95% CI5 95% confidence interval.
† Analyses adjusted for randomized groups from the Prevention of Knee Osteoarthritis in Overweight
Females study and their interaction, Kellgren/Lawrence grade and body mass index at baseline, and
past injury. The non–weight loss group served as the reference group.
‡ Primary outcome measure and defined as incidence of Kellgren/Lawrence grade $2 or by American
College of Rheumatology criteria (clinical and radiographic) or by joint space narrowing $1.0 mm.
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Framingham Osteoarthritis Study (2% in women) (34), the
Rotterdam study (1.4% in men and women with a BMI
.27.5 kg/m2), the Chingford Women’s Study (2.3% in
women ages 45–64 years) (35), and the ROAD study (3.6%
in women ages 50–59 years) (36). Only the ROAD study
reported higher incidence numbers than our study, but
these were calculated on a subject level rather than on a
knee level. On a subject level, an annual incidence of 4%
was found in the non–weight loss group. The incidence of
clinical knee OA (clinical and radiographic) found in the
present study (2.8% in the non–weight loss group) was
higher than that reported in other studies (1% in women of
the Framingham Osteoarthritis Study and 0.3% in middle-
aged women) (34,37). This could possibly be explained by
the fact that our study was conducted on overweight and
obese subjects, who are at higher risk for the onset of knee
OA than normal-weight individuals (2,3).
There is an obvious overlap between the incidence of
JSN and of a K/L grade $2, given that JSN is part of the
definition of a K/L grade $2. Nevertheless, we did not
find a similar association between weight loss and inci-
dent JSN like we found for the incidence of a K/L grade
$2. In addition to JSN, a K/L grade $2 requires definite
osteophytes in the tibiofemoral joint. Previously, surplus
fat mass has been linked to osteophyte formation, possibly
through circulating leptin levels (38). Since circulating
leptin level decrease after weight loss (38), it could be sup-
posed that clinically relevant weight loss would lead to
less osteophyte formation. Less osteophyte formation
could explain why we found an effect of weight loss on
the incidence of a K/L grade$2, and not for JSN.
At baseline, the weight loss group had a significantly
higher BMI and reported a greater number of knees with a
history of knee injury. The first was to be expected, since a
high BMI is a predictor for greater weight loss (39,40).
Probably, the higher prevalence of knees with a history of
injury in the weight loss group was also linked to BMI;
baseline BMI was significantly higher in subjects with a
previously injured knee than in subjects without, and a
history of injury was shown to have a nonsignificant effect
on all outcome measures when adjusted for BMI at base-
line (data not shown). Perhaps the former injury led to a
less active lifestyle and, hence, a higher body weight.
Besides effects on the onset of knee OA, moderate
weight loss also positively affected several health mea-
sures, such as blood glucose level, fat percentage, waist
circumference, and blood pressure. Positive alterations in
these features have been linked to reduced risk of type 2
diabetes mellitus and cardiovascular morbidity and mor-
tality (41). However, the magnitude of the changes found
was not high enough to reduce the 10-year risk of fatal car-
diovascular disease (41). Maintenance of body weight in
the weight loss group over a prolonged period would pos-
sibly lead to greater reductions in these health measures.
Other limitations of this study include the observational
design, which makes the results less applicable in clinical
practice, since the intervention effect of the original ran-
domized controlled trial was adjusted for in the analyses,
thereby making this article a proof-of-concept. In addition,
a limitation of this study is that an association is found
between significant weight loss and the development of
knee OA, which does not necessarily mean that a causal
relation between these 2 variables exists. Confounding
factors could distort this association. For example, a sec-
ondary analysis on data derived from the PROOF study
showed, among other things, that participants with a rela-
tively low body weight around their 40th year of life were
more likely to lose weight during the study (42). This
could mean that the group that lost 5 kg or 5% of their
body weight is, in fact, a group of participants with an
overall healthier lifestyle, which could account for the
better health outcomes. However, the changes in health
outcomes were measured during the period in which the
participants lost weight. It is not expected that their blood
pressure and HbA1c level would lower spontaneously.
In conclusion, a reduction of $5 kg or 5% of body
weight over a 30-month period is associated with a
reduced risk of the onset of (radiographic) knee OA in
middle-aged overweight and obese women. Also, several
health measures were positively altered after this moder-
ate weight loss. Due to the slow progress of the disease, a
longer followup period will be necessary before the num-
ber of prevented cases of knee OA by moderate weight
loss becomes clinically relevant.
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